Limited Period Offer:Be a PRO for 1 month @Rs49/-Multiple payment options available. Know More
you are here: HomeNewsIndia

COVID-19 outbreak, deaths confined to limited areas due to lockdown: Govt

"Despite being such a large nation, due to lockdown, the outbreak of the infection has remained confined to limited areas," chairman of Empowered Group One and Niti Aayog member V K Paul said at a briefing.

May 23, 2020 / 08:29 AM IST

The outbreak of the novel coronavirus infection and deaths due to it have remained confined to limited areas, most of which are urban, due to the implementation of the lockdown, the government said on Friday. Also, the number of COVID-19 cases would have risen exponentially had the lockdown not been imposed, it said, adding that the doubling time of cases now stands at 13.3 days as against 3.4 days before the lockdown.

"Despite being such a large nation, due to lockdown, the outbreak of the infection has remained confined to limited areas," chairman of Empowered Group One and Niti Aayog member V K Paul said at a briefing.

Around 80 per cent of the active cases reported till Thursday are in just five states -- Maharashtra, Tamil Nadu, Gujarat, Delhi and Madhya Pradesh -- and over 90 per cent are in ten states, he elaborated.

Also, over 60 per cent of the cases are in just five cities -- Mumbai, Delhi, Chennai, Ahmedabad and Thane -- and over 70 per cent are in 10 cities, he added.

As far as fatalities are concerned, Paul said, over 80 per cent of them are in five states -- Maharashtra, Gujarat, Madhya Pradesh, West Bengal and Delhi -- and around 95 per cent are in ten states.


COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

"You can say this is a disease of the urban districts and nearly 60 per cent of the deaths were reported in five cities -- Mumbai, Ahmadabad, Pune, Delhi and Kolkata -- and 70 per cent of the deaths are in ten cities," he said.

"The confinement of COVID-19 to certain areas has been due to the actions taken during lockdown. It enabled us to be more prepared for the future," he added, highlighting how the the health infrastructure was ramped up in less than two months.

Now, there are 1,093 dedicated COVID facilities and around 1,85,306 beds have been prepared for treatment of such patients across the country.

Also, 2,403 dedicated COVID-19 health centres with oxygen facilities with a capacity of 1,38,652 isolation beds have been readied.

So around 3,24,000 beds have been prepared in hospitals by state governments and district administrations across the country.

Additionally, 6.5 lakh beds are available in COVID care centres to keep mild cases.

Besides, the human resources have been increased and 56 lakh trainings have been conducted for COVID warriors and the capacity of testing has been increased to about 1 lakh per day now.

"Also, 30 lakh PPEs have been given to states, 109 domestic manufacturers enlisted with 3 lakh per day domestic PPE manufacturing capacity," Paul said.

Also, on the digital front, Aarogya Setu is an unequalled weapon to fight the disease and the mobile application now has more than 10 crore users, he said.

Use of telemedicine has become more popular, guidelines have been framed promptly and it is being used in a timely manner, he added.

"The clinical experience gained during COVID-19 has given us confidence in patient management and in navigating the road ahead. Due to lockdown, we have been able to control infection, keep mortality low and prepare better," Paul said.

The time the nation got for preparedness due to lockdown has been utilised very well, he said, adding, "We can now say with confidence that we will be able to face the challenge and surmount it."

"This is not just a battle but has turned into a 'Jan Andolan'. Awareness is not enough, change in behaviour is required. We have to be very cautious. If we relax, virus will spread," he cautioned.

Paul urged people to seek treatment in time and not hide their symptoms. He also asked the public not to stigmatise the diseased.

Addressing the press briefing, joint secretary in the health ministry Lav Agarwal said the COVID-19 mortality rate has dropped from 3.13 per cent on May 19 to 3.02 per cent as the focus was on containment measures and clinical management of cases.
first published: May 22, 2020 08:15 am

stay updated

Get Daily News on your Browser